Therapeutic agents including radiation, poly-(ADP-ribose) polymerase inhibitors (PARPi), and etoposide can generate cytosolic DNA and induce STING-dependent interferon production for anti-tumor immunity22–24. The gene discussed is STING1; the disease is neoplasm.